Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/5/2025Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development
  • 8/5/2025China Approves AstraZeneca's Ultomiris for AQP4+ NMOSD
  • 8/5/2025Innovent Secures FDA Clearance to Begin U.S. Trials for Oral GLP-1 Dru...
  • 8/5/2025MediLink and Akeso Launch First Clinical Trial Combining Ivonescimab w...
  • 8/5/2025Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...
  • 8/5/2025China Biopharma Licensing Deals Soar in July, Driven by $500M Hengrui-...
  • 8/5/2025TenNor Files for Hong Kong IPO to Fund Breakthrough Antibacterial Prog...
  • 8/5/2025Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...
  • 8/5/2025China Seeks Public Feedback on New Internet Drug and Device Informatio...
  • 8/5/2025China Issues 2025 Code of Ethics for Medical Professionals
  • 8/5/2025Sanofi Withdraws Praluent from China Amid Strategic Shift
  • 8/4/2025China Officially Establishes New Launch Price Mechanism for Innovative...
  • 8/4/2025Novartis Submits Zolgensma for Approval in China with Priority Review ...
  • 8/4/2025Alphamab's JSKN022 ADC Clears Major Regulatory Hurdle, Highlights Prec...
  • 8/4/2025China Grants First-Time Approval to Eight New Drugs in July 2025
  • 8/4/2025I-Mab Announces Pricing of $65M Underwritten Offering of ADS
  • 8/2/2025Recent Official and Executive Moves
  • 8/2/2025PD‑L1×VEGF Bispecific from ImmuneOnco Shows Strong Efficacy in China...
  • 8/2/2025Sumitomo Pharma Completes Divestiture of China Business to Marubeni Gr...
  • 8/2/2025China's Innovative Drug Market Surpasses CNY 400 Billion, Commercial M...
  • 8/2/2025Attec Secures Strategic Series A Funding to Advance Protein Degrader P...
  • 8/1/2025Chipscreen's Brain-Penetrant Aurora B Selective Inhibitor Receives FDA...
  • 8/1/2025Shanghai UTC Therapeutics Secures FDA IND Clearance for Novel MSLN CAR...
  • 8/1/2025Mabgeek Clinches CNY 260M Pre‑IPO Boost and Advances MG‑K10 Commerc...
  • 8/1/2025TenNor Therapeutics IPO Application Accepted by HKEX
  • 8/1/2025Lepu Biopharma Licenses Two T‑Cell Engagers to Excalipoint
  • 8/1/2025Everest Makes Strategic Equity Investment in I-Mab to Advance Oncology...
  • 8/1/2025Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Cand...
  • 8/1/2025China's Biotech Sector Faces Geopolitical Headwinds as Asia-Pacific Em...
  • 8/1/2025Wuxi AppTec Raises Nearly US$1B in Hong Kong to Fuel Global Expansion
  • Page:3/56 Total number of articles:1678: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group